DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Rituxan (Rituximab) - Sepsis - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Sepsis ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rituxan (Rituximab) where reactions include sepsis. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Rituxan side effects in female

Reported by a physician from United States on 2012-08-02

Patient: female, weighing 141.5 kg (311.3 pounds)

Reactions: Leukocytoclastic Vasculitis, Hypotension, Sepsis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-17

Patient:

Reactions: Sepsis

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: B-Cell Lymphoma

Doxorubicin HCL
    Indication: B-Cell Lymphoma

Prednisone
    Indication: B-Cell Lymphoma

Rituxan
    Indication: B-Cell Lymphoma

Vincristine
    Indication: B-Cell Lymphoma



Possible Rituxan side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-17

Patient: male

Reactions: Fungal Infection, Sepsis

Adverse event resulted in: death

Drug(s) suspected as cause:
Chlorambucil
    Dosage: from day 20 to 29 of each 35 days cycle, cycle 1
    Indication: Mantle Cell Lymphoma

Chlorambucil
    Dosage: from day 20 to 29 of each 35 days cycle, cycle 2

Chlorambucil
    Dosage: from day 20 to 29 of each 35 days cycle, cycle 3

Chlorambucil
    Dosage: from day 20 to 29 of each 35 days cycle, cycle 4

Dexamethasone
    Dosage: from day 1 to 4 of each 35 days cycle, cycle 1
    Indication: Mantle Cell Lymphoma

Dexamethasone
    Dosage: from day 1 to 4 of each 35 days cycle, cycle 3

Dexamethasone
    Dosage: from day 1 to 4 of each 35 days cycle, cycle 2

Dexamethasone
    Dosage: from day 1 to 4 of each 35 days cycle, cycle 4

Doxorubicin HCL
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 3

Doxorubicin HCL
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 1
    Indication: Mantle Cell Lymphoma

Doxorubicin HCL
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 2

Doxorubicin HCL
    Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 4

Rituxan
    Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 2

Rituxan
    Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 3

Rituxan
    Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 1
    Indication: Mantle Cell Lymphoma

Rituxan
    Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 4

Velcade
    Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 2

Velcade
    Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 4

Velcade
    Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 3
    Indication: Mantle Cell Lymphoma

Velcade
    Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 1



Possible Rituxan side effects in

Reported by a consumer/non-health professional from Germany on 2012-06-21

Patient:

Reactions: Sepsis, Progressive Multifocal Leukoencephalopathy, Meningitis Tuberculous

Adverse event resulted in: death

Drug(s) suspected as cause:
Busulfan
    Dosage: 12 mg/kg, unk
    Indication: Product Used FOR Unknown Indication

Carboplatin
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Cisplatin
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Cyclophosphamide
    Dosage: 2000 mg/m2, unk
    Indication: Product Used FOR Unknown Indication

Doxorubicin Hydrochloride
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Etoposide
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Fludara
    Dosage: 250 mg/m2, unk
    Indication: Product Used FOR Unknown Indication

Ifosfamide
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Neupogen
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Prednisone TAB
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Rituxan
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Vincristine Sulfate
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Zevalin
    Dosage: unk
    Indication: Product Used FOR Unknown Indication



Possible Rituxan side effects in

Reported by a consumer/non-health professional from Canada on 2012-06-13

Patient:

Reactions: Sepsis, Progressive Multifocal Leukoencephalopathy, Meningitis Tuberculous

Adverse event resulted in: death

Drug(s) suspected as cause:
Busulfan
    Dosage: 12 mg/kg, qd
    Indication: Product Used FOR Unknown Indication

Carboplatin
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Cisplatin
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Cyclophosphamide
    Dosage: 2000 mg/m2, qd
    Indication: Product Used FOR Unknown Indication

Doxorubicin Hydrochloride
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Etoposide
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Fludara
    Dosage: 250 mg/m2, qd
    Indication: Product Used FOR Unknown Indication

Ifosfamide
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Neupogen
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Prednisone TAB
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Rituxan
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Vincristine Sulfate
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Zevalin
    Dosage: unk
    Indication: Product Used FOR Unknown Indication



Possible Rituxan side effects in 75 year old male

Reported by a physician from United States on 2012-05-17

Patient: 75 year old male

Reactions: Renal Failure, Respiratory Failure, Sepsis, Pulmonary Embolism

Adverse event resulted in: death

Drug(s) suspected as cause:
Rituxan
    Indication: Rheumatoid Arthritis
    Start date: 2012-03-13

Rituxan
    Start date: 2012-04-06

Rituxan
    Start date: 2012-03-27

Rituxan
    Start date: 2012-04-13



Possible Rituxan side effects in male

Reported by a physician from Romania on 2012-05-10

Patient: male, weighing 55.0 kg (121.0 pounds)

Reactions: Sepsis, Febrile Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Fludarabine Phosphate
    Indication: Mantle Cell Lymphoma

Rituxan
    Indication: Mantle Cell Lymphoma
    Start date: 2011-12-28
    End date: 2012-04-24

Other drugs received by patient: Acidum Ursodeoxycholicum; Vitamin B6; Arginin; Acyclovir; Silibinin; Acid Folic; Cotrim; Allopurinol



Possible Rituxan side effects in female

Reported by a consumer/non-health professional from United States on 2012-01-27

Patient: female

Reactions: Pneumonia, Sepsis

Adverse event resulted in: death

Drug(s) suspected as cause:
Humira
    Indication: Rheumatoid Arthritis

Remicade
    Indication: Product Used FOR Unknown Indication

Rituxan
    Indication: Product Used FOR Unknown Indication



Possible Rituxan side effects in male

Reported by a physician from United States on 2011-12-20

Patient: male, weighing 108.0 kg (237.6 pounds)

Reactions: Neutropenic Infection, Sepsis, Lymphopenia, Hypocalcaemia, Pancytopenia, Blood Sodium Abnormal, Blood Glucose Abnormal

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide

Cyclophosphamide
    End date: 2010-08-15

Cyclophosphamide
    Indication: Burkitt's Lymphoma Stage IV

Cyclophosphamide
    Start date: 2010-05-14

Cytarabine
    End date: 2010-08-15

Cytarabine
    Indication: Burkitt's Lymphoma Stage IV

Cytarabine
    Start date: 2010-05-14

Cytarabine

Doxorubicin HCL
    End date: 2010-08-15

Doxorubicin HCL

Doxorubicin HCL

Doxorubicin HCL
    Indication: Burkitt's Lymphoma Stage IV
    Start date: 2010-05-14

Etoposide
    End date: 2010-08-15

Etoposide

Etoposide
    Indication: Burkitt's Lymphoma Stage IV

Etoposide
    Start date: 2010-05-14

Filgrastim
    Start date: 2010-05-14

Filgrastim
    Indication: Burkitt's Lymphoma Stage IV

Filgrastim
    End date: 2010-08-15

Filgrastim

Ifosfamide
    Start date: 2010-05-14

Ifosfamide
    End date: 2010-08-15

Ifosfamide

Ifosfamide
    Indication: Burkitt's Lymphoma Stage IV

Leucovorin Calcium
    Start date: 2010-05-14

Leucovorin Calcium

Leucovorin Calcium
    Indication: Burkitt's Lymphoma Stage IV
    End date: 2010-08-15

Leucovorin Calcium

Methotrexate
    Indication: Burkitt's Lymphoma Stage IV
    End date: 2010-08-15

Methotrexate

Methotrexate

Methotrexate
    Start date: 2010-05-14

Rituxan
    Indication: Burkitt's Lymphoma
    Start date: 2010-05-14

Rituxan
    End date: 2010-08-15

Rituxan

Rituxan

Vincristine

Vincristine

Vincristine
    Indication: Burkitt's Lymphoma Stage IV
    End date: 2010-08-15

Vincristine
    Start date: 2010-05-14

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014